Contact Lens Solution Toxicity
3
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Optifree Puremoist
Research Leaders
6 sponsors active, led by Abbott Medical Optics
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (3)
Efficacy and Safety of cleadewGP for Rigid Contact Lenses
The Physiological Consequence of Silicone-hydrogel Care-solution Bio-incompatibility
Assessing Patient Comfort With Two Different Multi-Purpose Disinfecting Solutions
Research Network
Common Treatments
- Optifree Puremoist1
- Purevision Lenses Soaked In Renu Multiplus1
- Ophtecs Cleadew Gp1
- Purevision Lenses Soaked In Optifree Replenish1
- Revitalens1
Active Sponsors
- Abbott Medical Optics1
- Alcon Research1
- Ophtecs Corporation1
- Southern California College of Optometry at Marshall B. Ketchum University1
- The Hong Kong Polytechnic University1
Top Investigators
Southern California College of Optometry at Marshall B. Ketchum University
The Hong Kong Polytechnic University